Related Experiment Videos

Antibodies to Chlamydia pneumoniae and haemostatic factors in acute coronary syndrome without ST segment elevation

Zofia Grabczewska1, Edmund Nartowicz, Ludmiła Szymaniak

  • 1Department of Cardiology and Internal Diseases, Medical Academy, Bydgoszcz.

Kardiologia Polska
|August 15, 2003
PubMed

Insights

Chlamydia pneumoniae infection is linked to higher fibrinogen levels in acute coronary syndrome patients. However, no significant association was found with other key haemostatic factors.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Hematology

Background:

  • Chronic infections like Chlamydia pneumoniae are implicated in atherosclerosis development.
  • The link between C. pneumoniae infection and haemostatic factors, crucial in atherosclerosis, remains unclear.

Purpose of the Study:

  • To investigate the association between C. pneumoniae-specific IgA and IgG antibodies and haemostatic factors in acute coronary syndrome (ACS) patients.

Main Methods:

  • Serum antibodies to C. pneumoniae and haemostatic factors (vWF, TM, tPA, PAI-1, fibrinogen) were measured in 31 ACS patients.
  • Patients had ACS without ST segment elevation.

Main Results:

  • Chlamydia pneumoniae seropositivity was observed in 35.4% of patients.
  • A significant association was found between C. pneumoniae-specific IgG antibodies and elevated fibrinogen levels (p=0.05).
  • No significant relationships were identified between C. pneumoniae infection and vWF, TM, tPA, or PAI-1 levels.

Conclusions:

  • C. pneumoniae infection is not significantly associated with increased levels of most measured haemostatic factors in ACS patients.
  • Fibrinogen levels may be an exception, showing a potential link with C. pneumoniae-specific IgG antibodies.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...